Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics

World Journal of Gastroenterology

Volumn 20, Issue 42, 2014, Pages 15632-15649

  Plaza Diaz, Julio ^a   Gomez Llorente, Carolina ^a   Fontana, Luis ^a   Gil, Angel ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Gene expression; Gut; Immunity; Immunotolerance; Inflammation; Liver; Microbiota; Probiotics

Indexed keywords

PROBIOTIC AGENT; AUTACOID;

ARTICLE; DENDRITIC CELL; ENTERITIS; EXPERIMENTAL DIGESTIVE SYSTEM DISEASE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEPATITIS; HUMAN; IMMUNOMODULATION; INTESTINE CELL; LACTOBACILLUS RHAMNOSUS; NECROTIZING ENTEROCOLITIS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; SYSTEMATIC REVIEW (TOPIC); ULCERATIVE COLITIS; ANIMAL; BACTERIUM; DISEASE MODEL; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; INTESTINE; LIVER; LIVER DISEASES; METABOLISM; MICROBIOLOGY;

ANIMALS; BACTERIA; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTESTINES; LIVER; LIVER DISEASES; PROBIOTICS;

EID: 84912075083     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i42.15632     Document Type: Article

References (105)

1. Guarner F. Prebiotics, probiotics and helminths: The 'natural'solution? Dig Dis 2009; 27: 412-417 [PMID: 19786773 DOI: 10.1159/000228582]
2. Shanahan F. Therapeutic implications of manipulating and mining the microbiota. J Physiol 2009; 587: 4175-4179 [PMID: 19505978 DOI: 10.1113/jphysiol.2009.174649]
3. Food And Agriculture Organization/World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001
4. Giahi L, Aumueller E, Elmadfa I, Haslberger AG. Regulation of TLR4, p38 MAPkinase, I?B and miRNAs by inactivated strains of lactobacilli in human dendritic cells. Benef Microbes 2012; 3: 91-98 [PMID: 22476320 DOI: 10.3920/BM2011.0052]
5. Fontana L, Bermudez-Brito M, Plaza-Diaz J, Muñoz-Quezada S, Gil A. Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr 2013; 109 Suppl 2: S35-S50 [PMID: 23360880 DOI: 10.1017/S0007114512004011]
6. Collado MC, Isolauri E, Salminen S, Sanz Y. The impact of probiotic on gut health. Curr Drug Metab 2009; 10: 68-78 [PMID: 19149514 DOI: 10.2174/138920009787048437]
7. Bermudez-Brito M, Muñoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, Romero F, Gil A. Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR activation. PLoS One 2012; 7: E43197 [PMID: 22905233 DOI: 10.1371/journal.pone.0043197]
8. Bongaerts GP, Severijnen RS. Preventive and curative effects of probiotics in atopic patients. Med Hypotheses 2005; 64: 1089-1092 [PMID: 15823690 DOI: 10.1016/j.mehy.2004.10.018]
9. Ouwehand AC, Nermes M, Collado MC, Rautonen N, Salminen S, Isolauri E. Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol 2009; 15: 3261-3268 [PMID: 19598302 DOI: 10.3748/wjg.15.3261]
10. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children: A metaanalysis. Dig Dis Sci 2002; 47: 2625-2634 [PMID: 12452406 DOI: 10.1023/A: 1020501202369]
11. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J Gastroenterol 2009; 44: 26-46 [PMID: 19159071 DOI: 10.1007/s00535-008-2296-0]
12. Williams NT. Probiotics. Am J Health Syst Pharm 2010; 67: 449-458 [PMID: 20208051 DOI: 10.2146/ajhp090168]
13. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab 2012; 61: 160-174 [PMID: 23037511 DOI: 10.1159/000342079]
14. Ghadimi D, Vrese Md, Heller KJ, Schrezenmeir J. Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells. Inflamm Bowel Dis 2010; 16: 410-427 [PMID: 19714766 DOI: 10.1002/ibd.21057]
15. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8: 411-420 [PMID: 18469830 DOI: 10.1038/nri2316]
16. Gómez-Llorente C, Muñoz S, Gil A. Role of Toll-like receptors in the development of immunotolerance mediated by probiotics. Proc Nutr Soc 2010; 69: 381-389 [PMID: 20416121 DOI: 10.1017/S0029665110001527]
17. Otte JM, Podolsky DK. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2004; 286: G613-G626 [PMID: 15010363 DOI: 10.1152/ajpgi.00341.2003]
18. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276: G941-G950 [PMID: 10198338]
19. Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, Roy NC. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol 2010; 10: 316 [PMID: 21143932 DOI: 10.1186/1471-2180-10-316]
20. Audy J, Mathieu O, Belvis J, Tompkins TA. Transcriptomic response of immune signalling pathways in intestinal epithelial cells exposed to lipopolysaccharides, Gram-negative bacteria or potentially probiotic microbes. Benef Microbes 2012; 3: 273-286 [PMID: 23234729 DOI: 10.3920/BM2012.0027]
21. Riedel CU, Foata F, Philippe D, Adolfsson O, Eikmanns BJ, Blum S. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World J Gastroenterol 2006; 12: 3729-3735 [PMID: 16773690 DOI: 10.3748/wjg.v12.i23.3729]
22. Ruiz PA, Hoffmann M, Szcesny S, Blaut M, Haller D. Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology 2005; 115: 441-450 [PMID: 16011513 DOI: 10.1111/j.1365-2567.2005.02176.x]
23. Liu C, Zhang ZY, Dong K, Guo XK. Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407. World J Gastroenterol 2010; 16: 2283-2290 [PMID: 20458767 DOI: 10.3748/wjg.v16. i18.2283]
24. Okada Y, Tsuzuki Y, Hokari R, Komoto S, Kurihara C, Kawaguchi A, Nagao S, Miura S. Anti-inflammatory effects of the genus Bifidobacterium on macrophages by modification of phospho-I kappaB and SOCS gene expression. Int J Exp Pathol 2009; 90: 131-140 [PMID: 19335551 DOI: 10.1111/j.1365-2613.2008.00632.x]
25. Imaoka A, Shima T, Kato K, Mizuno S, Uehara T, Matsumoto S, Setoyama H, Hara T, Umesaki Y. Anti-inflammatory activity of probiotic Bifidobacterium: Enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol 2008; 14: 2511-2516 [PMID: 18442197 DOI: 10.3748/wjg.14.2511]
26. Boesten RJ, Schuren FH, Willemsen LE, Vriesema A, Knol J, De Vos WM. Bifidobacterium breve -HT-29 cell line interaction: Modulation of TNF-A induced gene expression. Benef Microbes 2011; 2: 115-128 [PMID: 21831793 DOI: 10.3920/BM2011.0005]
27. Nishitani Y, Tanoue T, Yamada K, Ishida T, Yoshida M, Azuma T, Mizuno M. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice. Int Immunopharmacol 2009; 9: 1444-1451 [PMID: 19733697 DOI: 10.1016/j.intimp.2009.08.018]
28. O'Flaherty S, Klaenhammer TR. Influence of exposure time on gene expression by human intestinal epithelial cells exposed to Lactobacillus acidophilus. Appl Environ Microbiol 2012; 78: 5028-5032 [PMID: 22562992 DOI: 10.1128/AEM.00504-12]
29. Oksaharju A, Kankainen M, Kekkonen RA, Lindstedt KA, Kovanen PT, Korpela R, Miettinen M. Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells. World J Gastroenterol 2011; 17: 750-759 [PMID: 21390145 DOI: 10.3748/wjg.v17.i6.750]
30. Paszti-Gere E, Szeker K, Csibrik-Nemeth E, Csizinszky R, Marosi A, Palocz O, Farkas O, Galfi P. Metabolites of Lactobacillus plantarum 2142 prevent oxidative stress-induced overexpression of proinflammatory cytokines in IPEC-J2 cell line. Inflammation 2012; 35: 1487-1499 [PMID: 22476971 DOI: 10.1007/s10753-012-9462-5]
31. Zanello G, Berri M, Dupont J, Sizaret PY, D'Inca R, Salmon H, Meurens F. Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. PLoS One 2011; 6: E18573 [PMID: 21483702 DOI: 10.1371/journal. pone.0018573]
32. Latvala S, Miettinen M, Kekkonen RA, Korpela R, Julkunen I. Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages. Clin Exp Immunol 2011; 165: 94-103 [PMID: 21545585 DOI: 10.1111/j.1365-2249.2011.04408. x]
33. Ukena SN, Westendorf AM, Hansen W, Rohde M, Geffers R, Coldewey S, Suerbaum S, Buer J, Gunzer F. The host response to the probiotic Escherichia coli strain Nissle 1917: Specific up-regulation of the proinflammatory chemokine MCP-1. BMC Med Genet 2005; 6: 43 [PMID: 16351713 DOI: 10.1186/1471-2350-6-43]
34. Wang Y, Xie J, Wang N, Li Y, Sun X, Zhang Y, Zhang H. Lactobacillus casei Zhang modulate cytokine and toll-like receptor expression and beneficially regulate poly I: C-induced immune responses in RAW264.7 macrophages. Microbiol Immunol 2013; 57: 54-62 [PMID: 23350674 DOI: 10.1111/j.1348-0421.516.x]
35. Kim CH, Kim HG, Kim JY, Kim NR, Jung BJ, Jeong JH, Chung DK. Probiotic genomic DNA reduces the production of pro-inflammatory cytokine tumor necrosis factor-alpha. FEMS Microbiol Lett 2012; 328: 13-19 [PMID: 22126103 DOI: 10.1111/j.1574-6968.2011.02470.x]
36. Cammarota M, De Rosa M, Stellavato A, Lamberti M, Marzaioli I, Giuliano M. In vitro evaluation of Lactobacillus plantarum DSMZ 12028 as a probiotic: Emphasis on innate immunity. Int J Food Microbiol 2009; 135: 90-98 [PMID: 19748696 DOI: 10.1016/j.ijfoodmicro.2009.08.022]
37. Tomosada Y, Villena J, Murata K, Chiba E, Shimazu T, Aso H, Iwabuchi N, Xiao JZ, Saito T, Kitazawa H. Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression. PLoS One 2013; 8: E59259 [PMID: 23555642 DOI: 10.1371/journal.pone.0059259]
38. Gao Q, Qi L, Wu T, Wang J. Clostridium butyricum activates TLR2-mediated MyD88-independent signaling pathway in HT-29 cells. Mol Cell Biochem 2012; 361: 31-37 [PMID: 21956671 DOI: 10.1007/s11010-011-1084-y]
39. Isono A, Katsuno T, Sato T, Nakagawa T, Kato Y, Sato N, Seo G, Suzuki Y, Saito Y. Clostridium butyricum TO-A culture supernatant downregulates TLR4 in human colonic epithelial cells. Dig Dis Sci 2007; 52: 2963-2971 [PMID: 17404865 DOI: 10.1007/s10620-006-9593-3]
40. Huang JM, La Ragione RM, Nunez A, Cutting SM. Immunostimulatory activity of Bacillus spores. FEMS Immunol Med Microbiol 2008; 53: 195-203 [PMID: 18430003 DOI: 10.1111/j.1574-695X.2008.00415.x]
41. Drakes M, Blanchard T, Czinn S. Bacterial probiotic modulation of dendritic cells. Infect Immun 2004; 72: 3299-3309 [PMID: 15155633 DOI: 10.1128/IAI.72.6.3299-3309.2004]
42. Rizzello V, Bonaccorsi I, Dongarrà ML, Fink LN, Ferlazzo G. Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics. J Biomed Biotechnol 2011; 2011: 473097 [PMID: 21660136 DOI: 10.1155/2011/473097]
43. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000; 114: 295-302 [PMID: 10651989 DOI: 10.1046/j.1523-1747.2000.00881.x]
44. de Jong EC, Vieira PL, Kalinski P, Schuitemaker JH, Tanaka Y, Wierenga EA, Yazdanbakhsh M, Kapsenberg ML. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol 2002; 168: 1704-1709 [PMID: 11823500]
45. Mastrangeli G, Corinti S, Butteroni C, Afferni C, Bonura A, Boirivant M, Colombo P, Di Felice G. Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses. Int Arch Allergy Immunol 2009; 150: 133-143 [PMID: 19439979 DOI: 10.1159/000218116]
46. D'Arienzo R, Maurano F, Lavermicocca P, Ricca E, Rossi M. Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity. Cytokine 2009; 48: 254-259 [PMID: 19736022 DOI: 10.1016/j.cyto.2009.08.003]
47. Kosaka A, Yan H, Ohashi S, Gotoh Y, Sato A, Tsutsui H, Kaisho T, Toda T, Tsuji NM. Lactococcus lactis subsp. cremoris FC triggers IFN-? production from NK and T cells via IL-12 and IL-18. Int Immunopharmacol 2012; 14: 729-733 [PMID: 23102661 DOI: 10.1016/j.intimp.2012.10.007]
48. Weiss G, Rasmussen S, Zeuthen LH, Nielsen BN, Jarmer H, Jespersen L, Frøkiaer H. Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism. Immunology 2010; 131: 268-281 [PMID: 20545783 DOI: 10.1111/j.1365-2567.2010.03301.x]
49. Rajput IR, Hussain A, Li YL, Zhang X, Xu X, Long MY, You DY, Li WF. Saccharomyces boulardii and Bacillus subtilis B10 modulate TLRs mediated signaling to induce immunity by chicken BMDCs. J Cell Biochem 2014; 115: 189-198 [PMID: 24038094 DOI: 10.1002/jcb.24650]
50. Latvala S, Pietila TE, Veckman V, Kekkonen RA, Tynkkynen S, Korpela R, Julkunen I. Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J Gastroenterol 2008; 14: 5570-5583; discussion 5581-5582 [PMID: 18810777 DOI: 10.3748/wjg.14.5570]
51. O'Hara AM, O'Regan P, Fanning A, O'Mahony C, Macsharry J, Lyons A, Bienenstock J, O'Mahony L, Shanahan F. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006; 118: 202-215 [PMID: 16771855 DOI: 10.1111/j.1365-2567.2006.02358.x]
52. Evrard B, Coudeyras S, Dosgilbert A, Charbonnel N, Alamé J, Tridon A, Forestier C. Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS One 2011; 6: E18735 [PMID: 21533162 DOI: 10.1371/journal.pone.0018735]
53. Torri A, Beretta O, Ranghetti A, Granucci F, Ricciardi-Castagnoli P, Foti M. Gene expression profiles identify inflammatory signatures in dendritic cells. PLoS One 2010; 5: E9404 [PMID: 20195376 DOI: 10.1371/journal.pone.0009404]
54. Tsilingiri K, Barbosa T, Penna G, Caprioli F, Sonzogni A, Viale G, Rescigno M. Probiotic and postbiotic activity in health and disease: Comparison on a novel polarised exvivo organ culture model. Gut 2012; 61: 1007-1015 [PMID: 22301383 DOI: 10.1136/gutjnl-2011-300971]
55. Bermudez-Brito M, Muñoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, Romero F, Gil A. Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PLoS One 2013; 8: E59370 [PMID: 23555025 DOI: 10.1371/journal.pone.0059370]
56. Ayehunie S, Snell M, Child M, Klausner M. A plasmacytoid dendritic cell (CD123+/CD11c-) based assay system to predict contact allergenicity of chemicals. Toxicology 2009; 264: 1-9 [PMID: 19665512 DOI: 10.1016/j.tox.2009.07.021]
57. Matsumoto M, Kurihara S, Kibe R, Ashida H, Benno Y. Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production. PLoS One 2011; 6: E23652 [PMID: 21858192 DOI: 10.1371/journal.pone.0023652]
58. Ohtsuka Y, Ikegami T, Izumi H, Namura M, Ikeda T, Ikuse T, Baba Y, Kudo T, Suzuki R, Shimizu T. Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestine. Pediatr Res 2012; 71: 46-53 [PMID: 22289850 DOI: 10.1038/pr.2011.11]
59. Trevisi P, De Filippi S, Minieri L, Mazzoni M, Modesto M, Biavati B, Bosi P. Effect of fructo-oligosaccharides and different doses of Bifidobacterium animalis in a weaning diet on bacterial translocation and Toll-like receptor gene expression in pigs. Nutrition 2008; 24: 1023-1029 [PMID: 18562167 DOI: 10.1016/j.nut.2008.04.008]
60. Dykstra NS, Hyde L, Adawi D, Kulik D, Ahrne S, Molin G, Jeppsson B, Mackenzie A, Mack DR. Pulse probiotic administration induces repeated small intestinal Muc3 expression in rats. Pediatr Res 2011; 69: 206-211 [PMID: 21135754 DOI: 10.1203/PDR.0b013e3182096ff0]
61. Finamore A, Roselli M, Britti MS, Merendino N, Mengheri E. Lactobacillus rhamnosus GG and Bifidobacterium animalis MB5 induce intestinal but not systemic antigenspecific hyporesponsiveness in ovalbumin-immunized rats. J Nutr 2012; 142: 375-381 [PMID: 22223570 DOI: 10.3945/jn.111.148924]
62. Foye OT, Huang IF, Chiou CC, Walker WA, Shi HN. Early administration of probiotic Lactobacillus acidophilus and/or prebiotic inulin attenuates pathogen-mediated intestinal inflammation and Smad 7 cell signaling. FEMS Immunol Med Microbiol 2012; 65: 467-480 [PMID: 22524476 DOI: 10.1111/j.1574-695X.2012.00978.x]
63. Deng J, Li Y, Zhang J, Yang Q. Co-administration of Bacillus subtilis RJGP16 and Lactobacillus salivarius B1 strongly enhances the intestinal mucosal immunity of piglets. Res Vet Sci 2013; 94: 62-68 [PMID: 22901748 DOI: 10.1016/j.rvsc.2012.07.025]
64. Jain S, Yadav H, Sinha PR, Marotta F. Modulation of cytokine gene expression in spleen and Peyer's patches by feeding dahi containing probiotic Lactobacillus casei in mice. J Dig Dis 2009; 10: 49-54 [PMID: 19236547 DOI: 10.1111/j.1751-2980.2008.00362.x]
65. Pérez-Sánchez T, Balcázar JL, Merrifield DL, Carnevali O, Gioacchini G, de Blas I, Ruiz-Zarzuela I. Expression of immune-related genes in rainbow trout (Oncorhynchus mykiss) induced by probiotic bacteria during Lactococcus garvieae infection. Fish Shellfish Immunol 2011; 31: 196-201 [PMID: 21620974 DOI: 10.1016/j.fsi.2011.05.005]
66. Pirarat N, Pinpimai K, Endo M, Katagiri T, Ponpornpisit A, Chansue N, Maita M. Modulation of intestinal morphology and immunity in nile tilapia (Oreochromis niloticus) by Lactobacillus rhamnosus GG. Res Vet Sci 2011; 91: E92-e97 [PMID: 21536310 DOI: 10.1016/j.rvsc.2011.02.014]
67. van Baarlen P, Troost F, van der Meer C, Hooiveld G, Boekschoten M, Brummer RJ, Kleerebezem M. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci USA 2011; 108 Suppl 1: 4562-4569 [PMID: 20823239 DOI: 10.1073/pnas.1000079107]
68. Lammers KM, Vergopoulos A, Babel N, Gionchetti P, Rizzello F, Morselli C, Caramelli E, Fiorentino M, d'Errico A, Volk HD, Campieri M. Probiotic therapy in the prevention of pouchitis onset: Decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis 2005; 11: 447-454 [PMID: 15867584 DOI: 10.1097/01. mpa.0000160302.40931.7b]
69. Di Caro S, Tao H, Grillo A, Franceschi F, Elia C, Zocco MA, Gasbarrini G, Sepulveda AR, Gasbarrini A. Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis. Eur J Gastroenterol Hepatol 2005; 17: 951-960 [PMID: 16093873]
70. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33 [PMID: 17631127 DOI: 10.1053/j.gastro.2007.04.005]
71. Distrutti E, Cipriani S, Mencarelli A, Renga B, Fiorucci S. Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. PLoS One 2013; 8: E63893 [PMID: 23691109 DOI: 10.1371/journal. pone.0063893]
72. Ghadimi D, Helwig U, Schrezenmeir J, Heller KJ, de Vrese M. Epigenetic imprinting by commensal probiotics inhibits the IL-23/IL-17 axis in an in vitro model of the intestinal mucosal immune system. J Leukoc Biol 2012; 92: 895-911 [PMID: 22730546 DOI: 10.1189/jlb.0611286]
73. Grimoud J, Durand H, de Souza S, Monsan P, Ouarné F, Theodorou V, Roques C. In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. Int J Food Microbiol 2010; 144: 42-50 [PMID: 20951454 DOI: 10.1016/j.ijfoodmicro.2010.09.007]
74. Chen X, Yang G, Song JH, Xu H, Li D, Goldsmith J, Zeng H, Parsons-Wingerter PA, Reinecker HC, Kelly CP. Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation. PLoS One 2013; 8: E64227 [PMID: 23675530 DOI: 10.1371/journal.pone.0064227]
75. Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Hontecillas R. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One 2012; 7: E34676 [PMID: 22511958 DOI: 10.1371/journal.pone.0034676]
76. Garrido-Mesa N, Utrilla P, Comalada M, Zorrilla P, Garrido-Mesa J, Zarzuelo A, Rodríguez-Cabezas ME, Gálvez J. The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice. Biochem Pharmacol 2011; 82: 1891-1900 [PMID: 21930116 DOI: 10.1016/j.bcp.2011.09.004]
77. Claes IJ, Lebeer S, Shen C, Verhoeven TL, Dilissen E, De Hertogh G, Bullens DM, Ceuppens JL, Van Assche G, Vermeire S, Rutgeerts P, Vanderleyden J, De Keersmaecker SC. Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol 2010; 162: 306-314 [PMID: 20731672 DOI: 10.1111/j.1365-2249.2010.04228.x]
78. Miyauchi E, Morita H, Tanabe S. Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J Dairy Sci 2009; 92: 2400-2408 [PMID: 19447972 DOI: 10.3168/jds.2008-1698]
79. Mariman R, Kremer B, van Erk M, Lagerweij T, Koning F, Nagelkerken L. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics. Inflamm Bowel Dis 2012; 18: 1424-1433 [PMID: 22162025 DOI: 10.1002/ibd.22849]
80. Amit-Romach E, Uni Z, Reifen R. Multistep mechanism of probiotic bacterium, the effect on innate immune system. Mol Nutr Food Res 2010; 54: 277-284 [PMID: 19998380 DOI: 10.1002/mnfr.200800591]
81. Duary RK, Bhausaheb MA, Batish VK, Grover S. Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Mol Biol Rep 2012; 39: 4765-4775 [PMID: 21947851 DOI: 10.1007/s11033-011-1269-1]
82. Grompone G, Martorell P, Llopis S, González N, Genovés S, Mulet AP, Fernández-Calero T, Tiscornia I, Bollati-Fogolín M, Chambaud I, Foligné B, Montserrat A, Ramón D. Antiinflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans. PLoS One 2012; 7: E52493 [PMID: 23300685 DOI: 10.1371/journal.pone.0052493]
83. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'neil DA, Macfarlane GT. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut 2005; 54: 242-249 [PMID: 15647189 DOI: 10.1136/gut.2004.044834]
84. D'Souza A, Fordjour L, Ahmad A, Cai C, Kumar D, Valencia G, Aranda JV, Beharry KD. Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr Res 2010; 67: 526-531 [PMID: 20101198 DOI: 10.1203/PDR.0b013e3181d4ff2b]
85. Lin PW, Nasr TR, Berardinelli AJ, Kumar A, Neish AS. The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut. Pediatr Res 2008; 64: 511-516 [PMID: 18552706 DOI: 10.1203/PDR.0b013e3181827c0f]
86. Gomi A, Harima-Mizusawa N, Shibahara-Sone H, Kano M, Miyazaki K, Ishikawa F. Effect of Bifidobacterium bifidum BF-1 on gastric protection and mucin production in an acute gastric injury rat model. J Dairy Sci 2013; 96: 832-837 [PMID: 23200466 DOI: 10.3168/jds.2012-5950]
87. Mirpuri J, Sotnikov I, Myers L, Denning TL, Yarovinsky F, Parkos CA, Denning PW, Louis NA. Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit. PLoS One 2012; 7: E51955 [PMID: 23272193 DOI: 10.1371/journal.pone.0051955]
88. Delzenne NM, Cani PD. Interaction between obesity and the gut microbiota: Relevance in nutrition. Annu Rev Nutr 2011; 31: 15-31 [PMID: 21568707 DOI: 10.1146/annurevnutr-072610-145146]
89. Nolan JP. The contribution of gut-derived endotoxins to liver injury. Yale J Biol Med 1979; 52: 127-133 [PMID: 377823]
90. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: New insights into the gut microbiota. Curr Opin Pharmacol 2009; 9: 737-743 [PMID: 19628432 DOI: 10.1016/j.coph.2009.06.016]
91. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009; 15: 1546-1558 [PMID: 19442172 DOI: 10.2174/13816120 9788168164]
92. Lanthier N, Molendi-Coste O, Horsmans Y, van Rooijen N, Cani PD, Leclercq IA. Kupffer cell activation is a causal factor for hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol 2010; 298: G107-G116 [PMID: 19875703 DOI: 10.1152/ajpgi.00391.2009]
93. Neyrinck AM, Cani PD, Dewulf EM, De Backer F, Bindels LB, Delzenne NM. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. Biochem Biophys Res Commun 2009; 385: 351-356 [PMID: 19463788 DOI: 10.1016/j.bbrc.2009.05.070]
94. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995; 108: 218-224 [PMID: 7806045 DOI: 10.1016/0016-5085(95)90027-6]
95. Verdam FJ, Rensen SS, Driessen A, Greve JW, Buurman WA. Novel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitis. J Clin Gastroenterol 2011; 45: 149-152 [PMID: 20661154 DOI: 10.1097/MCG.0b013e3181e12c24]
96. Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, Tripathi G, Ashour E, Abdalla MS, Sharada HM, Amin AI, Burt AD, Kumar S, Day CP, McTernan PG. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond) 2010; 7: 15 [PMID: 20353583 DOI: 10.1186/1476-9255-7-15]
97. Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC, Bergheim I. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008; 138: 1452-1455 [PMID: 18641190]
98. Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM, Keshavarzian A. Susceptibility to gut leakiness: A possible mechanism for endotoxaemia in nonalcoholic steatohepatitis. Liver Int 2008; 28: 1026-1033 [PMID: 18397235 DOI: 10.1111/j.1478-3231.2008.01723.x]
99. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Mascianà R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009; 49: 1877-1887 [PMID: 19291785 DOI: 10.1002/hep.22848]
100. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58: 1091-1103 [PMID: 19240062 DOI: 10.1136/gut.2008.165886]
101. Bu HF, Wang X, Zhu YQ, Williams RY, Hsueh W, Zheng X, Rozenfeld RA, Zuo XL, Tan XD. Lysozyme-modified probiotic components protect rats against polymicrobial sepsis: Role of macrophages and cathelicidin-related innate immunity. J Immunol 2006; 177: 8767-8776 [PMID: 17142779]
102. Mair C, Plitzner C, Pfaffl MW, Schedle K, Meyer HH, Windisch W. Inulin and probiotics in newly weaned piglets: Effects on intestinal morphology, mRNA expression levels of inflammatory marker genes and haematology. Arch Anim Nutr 2010; 64: 304-321 [PMID: 20722301 DOI: 10.1080/17450 39X.2010.492137]
103. Angelakis E, Bastelica D, Ben Amara A, El Filali A, Dutour A, Mege JL, Alessi MC, Raoult D. An evaluation of the effects of Lactobacillus ingluviei on body weight, the intestinal microbiome and metabolism in mice. Microb Pathog 2012; 52: 61-68 [PMID: 22020311 DOI: 10.1016/j.micpath.2011.10.004]
104. D'Argenio G, Cariello R, Tuccillo C, Mazzone G, Federico A, Funaro A, De Magistris L, Grossi E, Callegari ML, Chirico M, Caporaso N, Romano M, Morelli L, Loguercio C. Symbiotic formulation in experimentally induced liver fibrosis in rats: Intestinal microbiota as a key point to treat liver damage? Liver Int 2013; 33: 687-697 [PMID: 23448378 DOI: 10.1111/liv.12117]
105. Zuo RY, Chang J, Yin QQ, Wang P, Yang YR, Wang X, Wang GQ, Zheng QH. Effect of the combined probiotics with aflatoxin B2-degrading enzyme on aflatoxin detoxification, broiler production performance and hepatic enzyme gene expression. Food Chem Toxicol 2013; 59: 470-475 [PMID: 23831311 DOI: 10.1016/j.fct.2013.06.044]